Correction: Anastassopoulou et al. Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines. Vaccines 2025, 13, 97

Affiliations

¹ Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
² Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
³ Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
⁴ Neurochemistry and Biological Markers Unit, 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.

Published Erratum

Cleo Anastassopoulou et al. Vaccines (Basel). 2025.

. 2025 Mar 27;13(4):354.

doi: 10.3390/vaccines13040354.

¹ Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
² Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
³ Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
⁴ Neurochemistry and Biological Markers Unit, 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.

Abstract

The authors would like to make the following corrections to this published paper [...].

Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.
Anastassopoulou C, Medić S, Ferous S, Boufidou F, Tsakris A. Anastassopoulou C, et al. Vaccines (Basel). 2025 Jan 21;13(2):97. doi: 10.3390/vaccines13020097. Vaccines (Basel). 2025. PMID: 40006644 Free PMC article. Review.

1. Anastassopoulou C., Medić S., Ferous S., Boufidou F., Tsakris A. Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines. Vaccines. 2025;13:97. doi: 10.3390/vaccines13020097. - DOI - PMC - PubMed